|
1
|
Estey EH: Acute myeloid leukemia: 2019
update on risk-stratification and management. Am J Hematol.
93:1267–1291. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brahimi-Horn MC, Chiche J and Pouysségur
J: Hypoxia and cancer. J Mol Med (Berl). 85:1301–1307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parmar K, Mauch P, Vergilio JA, Sackstein
R and Down JD: Distribution of hematopoietic stem cells in the bone
marrow according to regional hypoxia. Proc Natl Acad Sci USA.
104:5431–5436. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kubota Y, Takubo K and Suda T: Bone marrow
long label-retaining cells reside in the sinusoidal hypoxic niche.
Biochem Biophys Res Commun. 366:335–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schepers K, Campbell TB and Passegué E:
Normal and leukemic stem cell niches: Insights and therapeutic
opportunities. Cell Stem Cell. 16:254–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tabe Y and Konopleva M: Advances in
understanding the leukaemia microenvironment. Br J Haematol.
164:767–778. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Webb JD, Coleman ML and Pugh CW: Hypoxia,
hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen
sensing. Cell Mol Life Sci. 66:3539–3554. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wellmann S, Guschmann M, Griethe W, Eckert
C, von Stackelberg A, Lottaz C, Moderegger E, Einsiedel HG, Eckardt
KU, Henze G and Seeger K: Activation of HIF pathway in childhood
ALL, prognostic implications of VEGF. Leukemia. 18:926–933. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deeb G, Vaughan MM, McInnis I, Ford LA,
Sait SN, Starostik P, Wetzler M, Mashtare T and Wang ES:
Hypoxia-inducible factor-1α protein expression is associated with
poor survival in normal karyotype adult acute myeloid leukemia.
Leuk Res. 35:579–584. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song LP, Zhang J, Wu SF, Huang Y, Zhao Q,
Cao JP, Wu YL, Wang LS and Chen GQ: Hypoxia-inducible
factor-1alpha-induced differentiation of myeloid leukemic cells is
its transcriptional activity independent. Oncogene. 27:519–527.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Melki JR, Vincent PC and Clark SJ:
Concurrent DNA hypermethylation of multiple genes in acute myeloid
leukemia. Cancer Res. 59:3730–3740. 1999.PubMed/NCBI
|
|
13
|
Liu Q, Liu L, Zhao Y, Zhang J, Wang D,
Chen J, He Y, Wu J, Zhang Z and Liu Z: Hypoxia induces genomic DNA
demethylation through the activation of HIF-1α and transcriptional
upregulation of MAT2A in hepatoma cells. Mol Cancer Ther.
10:1113–1123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bristow RG and Hill RP: Hypoxia and
metabolism: Hypoxia, DNA repair and genetic instability. Nat Rev
Cancer. 8:180–192. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
McCarty G and Loeb DM: Hypoxia-sensitive
epigenetic regulation of an antisense-oriented lncRNA controls WT1
expression in myeloid leukemia cells. PLoS One. 10:e01198372015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tahiliani M, Koh KP, Shen Y, Pastor WA,
Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L and
Rao A: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in
mammalian DNA by MLL partner TET1. Science. 324:930–935. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li W and Liu M: Distribution of
5-hydroxymethylcytosine in different human tissues. J Nucleic
Acids. 2011:8707262011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nikoloski G, Langemeijer SM, Kuiper RP,
Knops R, Massop M, Tönnissen ER, van der Heijden A, Scheele TN,
Vandenberghe P, de Witte T, et al: Somatic mutations of the histone
methyltransferase gene EZH2 in myelodysplastic syndromes. Nat
Genet. 42:665–667. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Delhommeau F, Dupont S, Della Valle V,
James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F,
Alberdi A, et al: Mutation in TET2 in myeloid cancers. N Engl J
Med. 360:2289–2301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu YP, Lv L, Liu Y, Smith MD, Li WC, Tan
XM, Cheng M, Li Z, Bovino M, Aubé J and Xiong Y: Tumor suppressor
TET2 promotes cancer immunity and immunotherapy efficacy. J Clin
Invest. 129:4316–4331. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schumann U, Lee J, Kazan K, Ayliffe M and
Wang MB: DNA-Demethylase regulated genes show
methylation-independent spatiotemporal expression patterns. Front
Plant Sci. 8:14492017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nobori T, Miura K, Wu DJ, Lois A,
Takabayashi K and Carson DA: Deletions of the cyclin-dependent
kinase-4 inhibitor gene in multiple human cancers. Nature.
368:753–756. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hannon GJ and Beach D: p15INK4B is a
potential effector of TGF-beta-induced cell cycle arrest. Nature.
371:257–261. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Herman JG, Jen J, Merlo A and Baylin SB:
Hypermethylation-associated inactivation indicates a tumor
suppressor role for p15INK4B. Cancer Res. 56:722–727.
1996.PubMed/NCBI
|
|
25
|
Tien HF, Tang JH, Tsay W, Liu MC, Lee FY,
Wang CH, Chen YC and Shen MC: Methylation of the p15(INK4B) gene in
myelodysplastic syndrome: It can be detected early at diagnosis or
during disease progression and is highly associated with leukaemic
transformation. Br J Haematol. 112:148–154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, He N, Wang R, Tian T, Han F, Zhong
C, Zhang C, Hua M, Ji C and Ma D: Analysis of TET2 and EZH2 gene
functions in chromosome instability in acute myeloid leukemia. Sci
Rep. 10:27062020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeo EJ, Chun YS and Park JW: New
anticancer strategies targeting HIF-1. Biochem Pharmacol.
68:1061–1069. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Herman JG, Graff JR, Myohanen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lan F, Bayliss PE, Rinn JL, Whetstine JR,
Wang JK, Chen S, Iwase S, Alpatov R, Issaeva I, Canaani E, et al: A
histone H3 lysine 27 demethylase regulates animal posterior
development. Nature. 449:689–694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deynoux M, Sunter N, Hérault O and
Mazurier F: Hypoxia and hypoxia-inducible factors in leukemias.
Front Oncol. 6:412016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cui XY, Skretting G, Jing Y, Sun H,
Sandset PM and Sun L: Hypoxia influences stem cell-like properties
in multidrug resistant K562 leukemic cells. Blood Cells Mol Dis.
51:177–184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Piret JP, Mottet D, Raes M and Michiels C:
CoCl2, a chemical inducer of hypoxia-inducible factor-1,
and hypoxia reduce apoptotic cell death in hepatoma cell line
HepG2. Ann NY Acad Sci. 973:443–447. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee JW, Bae SH, Jeong JW, Kim SH and Kim
KW: Hypoxia-inducible factor (HIF-1) alpha: Its protein stability
and biological functions. Exp Mol Med. 36:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu T, Zhang C, Jing Y, Jiang C, Li Z, Wang
S, Ma K, Zhang D, Hou S, Dai J, et al: Regulation of cell growth
and apoptosis through lactate dehydrogenase C over-expression in
Chinese hamster ovary cells. Appl Microbiol Biotechnol.
100:5007–5016. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pasca S, Jurj A, Zdrenghea M and Tomuleasa
C: The potential equivalents of TET2 mutations. Cancers (Basel).
13:14992021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Song SJ, Ito K, Ala U, Kats L, Webster K,
Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J,
Avigan DE, et al: The oncogenic microRNA miR-22 targets the TET2
tumor suppressor to promote hematopoietic stem cell self-renewal
and transformation. Cell Stem Cell. 13:87–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng J, Guo S, Chen S, Mastriano SJ, Liu
C, D'Alessio AC, Hysolli E, Guo Y, Yao H, Megyola CM, et al: An
extensive network of TET2-targeting MicroRNAs regulates malignant
hematopoiesis. Cell Rep. 5:471–481. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Koh KP, Yabuuchi A, Rao S, Huang Y,
Cunniff K, Nardone J, Laiho A, Tahiliani M, Sommer CA, Mostoslavsky
G, et al: Tet1 and Tet2 regulate 5-hydroxymethylcytosine production
and cell lineage specification in mouse embryonic stem cells. Cell
Stem Cell. 8:200–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ko M, An J, Bandukwala HS, Chavez L, Aijö
T, Pastor WA, Segal MF, Li H, Koh KP, Lähdesmäki H, et al:
Modulation of TET2 expression and 5-methylcytosine oxidation by the
CXXC domain protein IDAX. Nature. 497:122–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cimmino L, Dolgalev I, Wang Y, Yoshimi A,
Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, et
al: Restoration of TET2 function blocks aberrant self-renewal and
leukemia progression. Cell. 170:1079–1095.e20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Harjes U: Leukaemia: Beyond the C. Nat Rev
Cancer. 17:5732017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thienpont B, Steinbacher J, Zhao H, D'Anna
F, Kuchnio A, Ploumakis A, Ghesquière B, Van Dyck L, Boeckx B,
Schoonjans L, et al: Tumor hypoxia causes DNA hypermethylation by
reducing TET activity. Nature. 537:63–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Choudhry H and Harris AL: Advances in
hypoxia-inducible factor biology. Cell Metab. 27:281–298. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lin YT and Wu KJ: Epigenetic regulation of
epithelial-mesenchymal transition: Focusing on hypoxia and TGF-β
signaling. J Biomed Sci. 27:392020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mikirova NA: Bioenergetics of human cancer
cells and normalcells during proliferation and differentiation. Br
J Med Med Res. 7:971–982. 2015. View Article : Google Scholar
|
|
47
|
Iaccarino I and Martins LM: Therapeutic
targets in cancer cell metabolism and death. Cell Death Differ.
18:565–570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tang S, Fang Y, Huang G, Xu X,
Padilla-Banks E, Fan W, Xu Q, Sanderson SM, Foley JF, Dowdy S, et
al: Methionine metabolism is essential for SIRT1-regulated mouse
embryonic stem cell maintenance and embryonic development. EMBO J.
36:3175–3193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Brand A, Singer K, Koehl GE, Kolitzus M,
Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, et
al: LDHA-associated lactic acid production blunts tumor
immunosurveillance by T and NK cells. Cell Metab. 24:657–671. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Galligan JJ, Wepy JA, Streeter MD,
Kingsley PJ, Mitchener MM, Wauchope OR, Beavers WN, Rose KL, Wang
T, Spiegel DA and Marnett LJ: Methylglyoxal-derived
posttranslational arginine modifications are abundant histone
marks. Proc Natl Acad Sci USA. 115:9228–9233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Christiansen DH, Andersen MK and
Pedersen-Bjergaard J: Methylation of p15INK4B is common, is
associated with deletion of genes on chromosome arm 7q and predicts
a poor prognosis in therapy-related myelodysplasia and acute
myeloid leukemia. Leukemia. 17:1813–1819. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yokoi K, Yamashita K and Watanabe M:
Analysis of DNA methylation status in bodily fluids for early
detection of cancer. Int J Mol Sci. 18:7352017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ramalho-Carvalho J, Henrique R and
Jerónimo C: Methylation-Specific PCR. Methods Mol Biol.
1708:447–472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fujii T, Otsuki T, Moriya T, Sakaguchi H,
Kurebayashi J, Yata K, Uno M, Kobayashi T, Kimura T, Jo Y, et al:
Effect of hypoxia on human seminoma cells. Int J Oncol. 20:955–962.
2002.PubMed/NCBI
|
|
55
|
Kroeze LI, Aslanyan MG, van Rooij A,
Koorenhof-Scheele TN, Massop M, Carell T, Boezeman JB, Marie JP,
Halkes CJ, de Witte T, et al: Characterization of acute
myeloidleukemia based on levels of global hydroxymethylation.
Blood. 124:1110–1118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Shimamoto T, Ohyashiki JH and Ohyashiki K:
Methylation of p15(INK4b) and E-cadherin genes is independently
correlated with poor prognosis in acute myeloid leukemia. Leuk Res.
29:653–659. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhao L, Duan YT, Lu P, Zhang ZJ, Zheng XK,
Wang JL and Feng WS: Epigenetic targets and their inhibitors in
cancer therapy. Curr Top Med Chem. 18:2395–2419. 2018. View Article : Google Scholar : PubMed/NCBI
|
